Wuxin Technology benefited from a significant year-on-year increase in overseas market revenue in the second quarter
六月清晨搅
发表于 2024-8-17 10:30:38
197
0
0
Fogchip Technology (NYSE: RLX) announced its unaudited financial report for the second quarter of 2024 on August 16th, benefiting from a significant year-on-year increase in overseas market revenue in the second quarter. According to the financial report, Wuxin Technology's net revenue for the second quarter of 2024 was RMB 630 million (USD 86.3 million), a month on month increase of 13.7% and a year-on-year increase of 65.9%. Under non GAAP accounting standards, the adjusted net profit for the second quarter was RMB 210 million (USD 29.32 million), an increase of 2.7% month on month and 147.1% year-on-year.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Apple AI goes live overseas
- Ford's revenue for the third quarter of this year was $46 billion, a year-on-year increase of 5%
- AMD's adjusted earnings per share for the third quarter met expectations, but its revenue outlook for the fourth quarter was not satisfactory
- AMD expects GPU sales to exceed $5 billion this year: Q4 revenue guidance falls short of expectations, market worries about AI demand
- Microsoft's first quarter revenue exceeded expectations
- Revenue and profit both decline, who is eating Nike's market
- Intel falls, AMD eats its fill! Wall Street predicts a significant decline in Intel's Q3 revenue
- JinkoSolar leads TOPCon technology upgrade, improving efficiency on the back and boosting overseas market demand
- Q4 revenue guidance falls short of expectations, Ideal US stock drops by over 13%, Li Xiang can still receive over 600 million yuan in equity incentives
- Investors suggest NIO to launch extended range models in overseas markets?
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 前天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 昨天 17:41
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 昨天 16:27
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 昨天 14:41
- 支持
- 反对
- 回复
- 收藏